These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23175432)
1. MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways. Zhang L; Yang L; Liu X; Chen W; Chang L; Chen L; Loera S; Chu P; Huang WC; Liu YR; Yen Y Hepatology; 2013 May; 57(5):1919-30. PubMed ID: 23175432 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma. Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302 [TBL] [Abstract][Full Text] [Related]
5. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
6. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Zhao L; Zhang Y Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008 [TBL] [Abstract][Full Text] [Related]
7. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis. Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494 [TBL] [Abstract][Full Text] [Related]
12. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α. Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053 [TBL] [Abstract][Full Text] [Related]
13. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Zhang X; Liu S; Hu T; Liu S; He Y; Sun S Hepatology; 2009 Aug; 50(2):490-9. PubMed ID: 19472311 [TBL] [Abstract][Full Text] [Related]
14. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Lang Q; Ling C Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133 [TBL] [Abstract][Full Text] [Related]
16. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis. Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
18. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412 [TBL] [Abstract][Full Text] [Related]
19. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]